Gangwon, South Korea

Eunhee G Kim

This inventor holds 1 USPTO granted patent. Top assignees: Kangwon National University Industry Cooperation Foundation, Seoul National University. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eunhee G Kim. Retrieved from https://idiyas.com/inventor/eunhee-g-kim

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Eunhee G Kim: Innovator in Monoclonal Antibody Development

Introduction

Eunhee G Kim is a prominent inventor based in Gangwon-do, South Korea. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. Her innovative work focuses on methods that enhance the production and efficacy of these antibodies, which are crucial for various medical applications.

Latest Patents

Eunhee G Kim holds a patent titled "Methods for preparing monoclonal antibodies recognizing glycan binding site as an epitope." This patent describes a method for producing monoclonal antibodies that specifically bind to the glycan binding site of glycoproteins. The method is designed to be relatively simple and cost-effective, allowing for the production of antibodies with high sensitivity and specificity. These antibodies can be effectively utilized in diagnosing or treating diseases associated with changes in glycan structure or expression levels.

Career Highlights

Throughout her career, Eunhee G Kim has worked with esteemed institutions such as Seoul National University and Kangwon National University Industry Cooperation Foundation. Her research has significantly advanced the understanding and application of monoclonal antibodies in medical science.

Collaborations

Eunhee G Kim has collaborated with notable colleagues, including Eugene C Yi and Min Jueng Kang. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation in the field.

Conclusion

Eunhee G Kim's contributions to the development of monoclonal antibodies represent a significant advancement in biotechnology. Her innovative methods and collaborative efforts continue to impact the medical field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…